ALFA Finder| Revenue growth | 12.3% YoY for FY26; 23.5% YoY for Q4FY26. |
|---|---|
| Margins | FY26 Gross Margin at 26.2%, up 180bps YoY. |
| Management confidence | High; emphasizing profitability of older stores and cluster leadership. |
Growth
FY26 Revenue grew 12.3% to ₹68,925m; PAT increased 46.2% to ₹2,196m. Q4FY26 revenue up 23.5% YoY.
Outlook
Targeting deeper penetration in existing clusters; extending <2 hour delivery; growing private label basket beyond 1550+ SKUs.
Risks
Expansion of new stores (<12 months) dragging consolidated margins initially; intense competition in omni-channel pharmacy retail.
Earnings Call filed with BSE, NSE: MEDPLUS. Summary written with AI assistance from the document.
Medplus Health Services Ltd: key numbers
- Share price
- ₹625.80
- Market cap
- ₹7,519 Cr
- Revenue (annual)
- ₹6,892 Cr
- Net profit (annual)
- ₹219.7 Cr
- P/E (TTM)
- 35.6×Sector 54.5×
- Promoter holding
- 40.19%+0.00% QoQ
- FII holding
- 12.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medplus Health Services Ltd
All →Medplus Health Services Adverse Business Impact
Medplus subsidiary Optival Health received a two-day drug licence suspension for its Kothagudem store. Expected financial impact is Rs 0.44 lacs, and compliance measures are underway.
- Value
- ₹0.00 Cr
Medplus Health Services Adverse Business Impact
MedPlus stores in Karnataka face four-day drug licence suspensions. Expected financial impact is about Rs 4.06 lacs.
- Value
- ₹0.04 Cr
- Execution
- Four days
Medplus Health Services Capital Structure Change
MedPlus approved a buyback of 17.33 lakh shares at ₹750 each, up to ₹130 crore. The buyback equals about 1% of paid-up capital via open market.
- Value
- ₹130.0 Cr
Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Medplus Health Services Board Meeting Date
MedPlus Health Services scheduled a board meeting for 6 November 2026 to consider a share buy-back. The trading window for designated persons closes from 30 October 2026.
Medplus Health Services Capital Structure Change
ICICI Prudential Mutual Fund disclosed under Regulation 29(2) that it bought 24,35,693 Medplus shares, lifting its stake to 9.21%. The acquisition was made in the open market, not off-market.
- Promoter stake change
- +1.97%